1. Home
  2. ARWR vs AGL Comparison

ARWR vs AGL Comparison

Compare ARWR & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • AGL
  • Stock Information
  • Founded
  • ARWR 2003
  • AGL 2016
  • Country
  • ARWR United States
  • AGL United States
  • Employees
  • ARWR N/A
  • AGL N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • AGL Managed Health Care
  • Sector
  • ARWR Health Care
  • AGL Health Care
  • Exchange
  • ARWR Nasdaq
  • AGL Nasdaq
  • Market Cap
  • ARWR 1.7B
  • AGL 1.4B
  • IPO Year
  • ARWR 1993
  • AGL 2021
  • Fundamental
  • Price
  • ARWR $11.24
  • AGL $4.00
  • Analyst Decision
  • ARWR Buy
  • AGL Hold
  • Analyst Count
  • ARWR 11
  • AGL 19
  • Target Price
  • ARWR $41.44
  • AGL $4.28
  • AVG Volume (30 Days)
  • ARWR 2.3M
  • AGL 6.4M
  • Earning Date
  • ARWR 05-08-2025
  • AGL 05-06-2025
  • Dividend Yield
  • ARWR N/A
  • AGL N/A
  • EPS Growth
  • ARWR N/A
  • AGL N/A
  • EPS
  • ARWR N/A
  • AGL N/A
  • Revenue
  • ARWR $2,500,000.00
  • AGL $6,060,530,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • AGL N/A
  • Revenue Next Year
  • ARWR $64.24
  • AGL $11.50
  • P/E Ratio
  • ARWR N/A
  • AGL N/A
  • Revenue Growth
  • ARWR N/A
  • AGL 40.41
  • 52 Week Low
  • ARWR $9.57
  • AGL $1.50
  • 52 Week High
  • ARWR $30.41
  • AGL $7.73
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 38.40
  • AGL 41.56
  • Support Level
  • ARWR $9.64
  • AGL $5.35
  • Resistance Level
  • ARWR $12.93
  • AGL $5.64
  • Average True Range (ATR)
  • ARWR 1.18
  • AGL 0.49
  • MACD
  • ARWR 0.18
  • AGL -0.03
  • Stochastic Oscillator
  • ARWR 43.21
  • AGL 27.27

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About AGL agilon health inc.

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Share on Social Networks: